Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial

BACKGROUND: Affecting approximately 10% of pregnancies, fetal growth restriction (FGR), is the most important cause of perinatal mortality and morbidity. Impaired placental function and consequent mal-perfusion of the placenta is the leading cause of FGR. Although, screening for placental insufficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Groten, T., Lehmann, T., Schleußner, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744635/
https://www.ncbi.nlm.nih.gov/pubmed/31521118
http://dx.doi.org/10.1186/s12884-019-2456-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744635/
https://www.ncbi.nlm.nih.gov/pubmed/31521118
http://dx.doi.org/10.1186/s12884-019-2456-7

Ejemplares similares